Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology
dc.contributor.author | Jeimy, Samira | |
dc.contributor.author | Ben-Shoshan, Moshe | |
dc.contributor.author | Abrams, Elissa M | |
dc.contributor.author | Ellis, Anne K | |
dc.contributor.author | Connors, Lori | |
dc.contributor.author | Wong, Tiffany | |
dc.date.accessioned | 2020-12-01T05:07:55Z | |
dc.date.issued | 2020-11-10 | |
dc.date.updated | 2020-12-01T05:07:55Z | |
dc.description.abstract | Abstract The vast majority of individuals labelled as allergic are not deemed truly allergic upon appropriate assessment by an allergist. A label of beta-lactam allergy carries important risks for individual and public health. This article provides an overview of beta-lactam allergy, implications of erroneous beta-lactam allergy labels and the impact that can be provided by structured allergy assessment. We provide recommendations on how to stratify risk of beta-lactam allergy, beta lactam challenge protocols as well as management of patients at high risk of beta-lactam allergy. | |
dc.identifier.citation | Allergy, Asthma & Clinical Immunology. 2020 Nov 10;16(1):95 | |
dc.identifier.uri | https://doi.org/10.1186/s13223-020-00494-2 | |
dc.identifier.uri | http://hdl.handle.net/1993/35146 | |
dc.language.rfc3066 | en | |
dc.rights | open access | en_US |
dc.rights.holder | The Author(s) | |
dc.title | Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology | |
dc.type | Journal Article |